These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 3280732)

  • 21. Transmission of Rift Valley fever virus by the sand fly, Phlebotomus duboscqi (Diptera: Psychodidae).
    Turell MJ; Perkins PV
    Am J Trop Med Hyg; 1990 Feb; 42(2):185-8. PubMed ID: 2316789
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A Genome-Wide RNA Interference Screen Identifies a Role for Wnt/β-Catenin Signaling during Rift Valley Fever Virus Infection.
    Harmon B; Bird SW; Schudel BR; Hatch AV; Rasley A; Negrete OA
    J Virol; 2016 Aug; 90(16):7084-7097. PubMed ID: 27226375
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Attenuation of pathogenic Rift Valley fever virus strain through the chimeric S-segment encoding sandfly fever phlebovirus NSs or a dominant-negative PKR.
    Nishiyama S; Slack OA; Lokugamage N; Hill TE; Juelich TL; Zhang L; Smith JK; Perez D; Gong B; Freiberg AN; Ikegami T
    Virulence; 2016 Nov; 7(8):871-881. PubMed ID: 27248570
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antigen-capture ELISA for the detection of Rift Valley fever virus nucleoprotein using new monoclonal antibodies.
    Fukushi S; Nakauchi M; Mizutani T; Saijo M; Kurane I; Morikawa S
    J Virol Methods; 2012 Mar; 180(1-2):68-74. PubMed ID: 22240075
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Packaging of Rift Valley fever virus pseudoviruses and establishment of a neutralization assay method.
    Li Y; Zhao Y; Wang C; Zheng X; Wang H; Gai W; Jin H; Yan F; Qiu B; Gao Y; Li N; Yang S; Xia X
    J Vet Sci; 2018 Mar; 19(2):200-206. PubMed ID: 28693302
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Differentiation of a human monocytic cell line associated with increased production of Rift Valley fever virus by infected cells.
    Lewis RM; Cosgriff TM; Peters CJ; Morrill JC
    J Med Virol; 1987 Nov; 23(3):207-15. PubMed ID: 3323414
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Epidemiology of Rift Valley fever in west Africa. 1. Serological investigation of small ruminants in Niger].
    Akakpo AJ; Saluzzo JF; Bada R; Bornarel P; Sarradin P
    Bull Soc Pathol Exot; 1991; 84(3):217-24. PubMed ID: 1764749
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of enzyme-linked immunosorbent assay systems using rift valley fever virus nucleocapsid protein and inactivated virus as antigens.
    Yu F; Adungo F; Konongoi SL; Inoue S; Sang R; Ashur S; Kwallah AO; Uchida L; Buerano CC; Mwau M; Zha Y; Nie Y; Morita K
    Virol J; 2018 Nov; 15(1):178. PubMed ID: 30466469
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Priming with DNA plasmids encoding the nucleocapsid protein and glycoprotein precursors from Rift Valley fever virus accelerates the immune responses induced by an attenuated vaccine in sheep.
    Lorenzo G; Martín-Folgar R; Rodríguez F; Brun A
    Vaccine; 2008 Sep; 26(41):5255-62. PubMed ID: 18682268
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Rift valley Fever in Kruger national park: do buffalo play a role in the inter-epidemic circulation of virus?
    Beechler BR; Bengis R; Swanepoel R; Paweska JT; Kemp A; van Vuren PJ; Joubert J; Ezenwa VO; Jolles AE
    Transbound Emerg Dis; 2015 Feb; 62(1):24-32. PubMed ID: 24330522
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Role of the cytosolic tails of Rift Valley fever virus envelope glycoproteins in viral morphogenesis.
    Carnec X; Ermonval M; Kreher F; Flamand M; Bouloy M
    Virology; 2014 Jan; 448():1-14. PubMed ID: 24314631
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Development of a Rift Valley fever virus viremia challenge model in sheep and goats.
    Weingartl HM; Miller M; Nfon C; Wilson WC
    Vaccine; 2014 Apr; 32(20):2337-44. PubMed ID: 24631070
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Host-based processes as therapeutic targets for Rift Valley fever virus.
    Pinkham C; Ahmed A; Bracci N; Narayanan A; Kehn-Hall K
    Antiviral Res; 2018 Dec; 160():64-78. PubMed ID: 30316916
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Four-segmented Rift Valley fever virus induces sterile immunity in sheep after a single vaccination.
    Wichgers Schreur PJ; Kant J; van Keulen L; Moormann RJ; Kortekaas J
    Vaccine; 2015 Mar; 33(12):1459-64. PubMed ID: 25665959
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Safety and immunogenicity of Rift Valley fever MP-12 and arMP-12ΔNSm21/384 vaccine candidates in goats (Capra aegagrus hircus) from Tanzania.
    Nyundo S; Adamson E; Rowland J; Palermo PM; Matiko M; Bettinger GE; Wambura P; Morrill JC; Watts DM
    Onderstepoort J Vet Res; 2019 Jan; 86(1):e1-e8. PubMed ID: 30843406
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Generation and characterization of monoclonal antibodies against Rift Valley fever virus nucleoprotein.
    Fafetine JM; Domingos A; Antunes S; Esteves A; Paweska JT; Coetzer JA; Rutten VP; Neves L
    Transbound Emerg Dis; 2013 Nov; 60 Suppl 2():24-30. PubMed ID: 24589098
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A ΩXaV motif in the Rift Valley fever virus NSs protein is essential for degrading p62, forming nuclear filaments and virulence.
    Cyr N; de la Fuente C; Lecoq L; Guendel I; Chabot PR; Kehn-Hall K; Omichinski JG
    Proc Natl Acad Sci U S A; 2015 May; 112(19):6021-6. PubMed ID: 25918396
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Reversed passive hemagglutination and inhibition with Rift Valley fever and Crimean-Congo hemorrhagic fever viruses.
    Swanepoel R; Struthers JK; McGillivray GM
    Am J Trop Med Hyg; 1983 May; 32(3):610-7. PubMed ID: 6407347
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A comparison of indirect immunofluorescence and electron microscopy for the diagnosis of some haemorrhagic viruses in cell cultures.
    El Mekki AA; van der Groen G
    J Virol Methods; 1981 Sep; 3(2):61-9. PubMed ID: 7024293
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Generation and application of monoclonal antibodies against Rift Valley fever virus nucleocapsid protein NP and glycoproteins Gn and Gc.
    Jäckel S; Eiden M; Dauber M; Balkema-Buschmann A; Brun A; Groschup MH
    Arch Virol; 2014 Mar; 159(3):535-46. PubMed ID: 24100475
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.